Percutaneous dilatational tracheostomy is a common bedside procedure in critical care for patients requiring prolonged mechanical ventilation. The traditional technique requires withdrawal of the endotracheal tube to a proximal position to facilitate tracheostomy insertion, but this carries the risk of inadvertent extubation and does not prevent cuff rupture. Use of a supraglottic airway such as the laryngeal mask airway may avoid these risks and could provide a safe alternative to the endotracheal tube. We present an appraisal of the literature to date. We found reasonable evidence to show improved ventilation and bronchoscopic visualisation with the laryngeal mask airway, but this has not been translated into improved outcome. There is currently insufficient evidence to draw conclusions about the safety of the laryngeal mask airway during percutaneous dilatational tracheostomy.
Percutaneous dilatational tracheostomy (PDT)
is a common bedside procedure in critical care for patients requiring prolonged mechanical ventilation, having shown reduced complications compared to surgical tracheostomy 1 . The traditional technique requires the cuff of the endotracheal tube (ETT) to be deflated and the tube withdrawn to lie just below the vocal cords in order to prevent damage during needle insertion and dilatation 2 . However this introduces the risk of inadvertent extubation during the procedure 3 and does not exclude cuff rupture.
Use of a supraglottic airway device such as the laryngeal mask airway (LMA) may offer a safe and advantageous alternative to the endotracheal tube during percutaneous tracheostomy.
QUESTION
In the general adult intensive care population does the laryngeal mask airway provide a safe and effective means of airway control during percutaneous dilatational tracheostomy?
Clinical bottom lines
The safety of the LMA for PDT has not been established and its use cannot be recommended for routine practice. Although statistically significant improvements in ventilation and endoscopic visualisation of the trachea have been demonstrated during PDT with the LMA, no study has shown that this improves patient outcome.
LITERATURE SEARCH
We searched the PubMed database, the Cochrane Central Register of Controlled Trials and Embase (to March 2011) using the terms "laryngeal mask" and "tracheostomy". This yielded 32 papers, including six randomised controlled trials, one cohort study, six case series and one retrospective study. The remaining papers were case reports and correspondence. Review of references in all 32 papers yielded one further randomised controlled trial and one case series.
SUMMARY OF FINDINGS
Use of the LMA for adult tracheostomy was first reported by Thomson in 1992 4 during two elective surgical tracheostomies in patients with ameloblastoma aboard a 'Mercy Ship'. The first patient was impossible to intubate and the LMA was again used in the second as it was perceived to be easier in the cramped operating room. Following this, several case series using the LMA for percutaneous dilatational tracheostomy were reported.
Dexter 5 multiple-dilator method. In five patients the procedure was completed successfully using an LMA, though a large air leak was noticed in the first patient in whom the nasogastric tube was left in situ. Tidal volumes were well maintained in the other four patients. A patient with an unstable C6 fracture was excluded and underwent surgical tracheostomy. In the remaining three patients the LMA was attempted but the vocal cords and larynx were found to be oedematous at bronchoscopy and tidal volume could not be maintained following advancement of the bronchoscope into the trachea. All three patients were reintubated prior to commencement of tracheostomy. Kahveci et al 6 reported a series of 18 consecutive patients. PDT was successfully performed via an LMA in 17 of these, but in one patient they were similarly unable to maintain ventilation. This patient had been intubated for 27 days and was noted to have an oedematous larynx. A further series by Rossi et al 7 reported 16 patients with a LMA in situ, including three in whom a large air leak was present. All tracheostomies were performed successfully with the original airway.
Other types of LMA have been investigated as they may offer particular advantages. Verghese et al 8 chose the intubating LMA for its potential to allow blind re-intubation and successfully performed 10 PDTs. Craven et al 9 preferred the ProSeal LMA, citing its integral drain tube and evidence of a better laryngeal seal. In two of the 23 patients in their study fluid appeared in the drain tube despite aspiration of the nasogastric tube prior to change of airway (the time of discontinuation of feeding is not reported) but no soiling of the trachea occurred. A larger observational study of 60 patients using the ProSeal LMA also reported four cases of gastric contents appearing in the drain tube despite withholding feed for six hours, aspiration of the nasogastric tube and premedication with metoclopramide 10 . Although the authors of both papers cite this as evidence of the benefits of the ProSeal LMA, no studies of other types of LMA have explicitly sought evidence of pharyngeal soiling. The results do suggest, however, that even during an elective tracheostomy the critically ill patient remains at extremely high risk for aspiration despite maximal precautions.
In two studies from the same institution the LMA was compared with the cuffed oropharyngeal airway. The first 11 studied 47 patients and found that the LMA was more likely to provide a patent airway (91.7 vs 87%, P=0.66 12 ) and required significantly less manipulation during PDT (0 vs 56.6%, P <0.001) compared to the cuffed oropharyngeal airway. The second 13 was a three-way randomised controlled trial of 96 patients comparing LMA, cuffed oropharyngeal airway and ETT. The cuffed oropharyngeal airway was again associated with an increased incidence of failure to maintain a patent airway compared to the LMA (9.7 vs 2.9%, P=0.33) and a significant increase in the requirement of manipulation during PDT (11.4 vs 45.2%, P <0.01), however no significant difference in complications between the three groups was reported.
The largest published dataset on the use of the LMA during PDT is from Cattano and colleagues 14 who retrospectively reviewed 254 consecutive PDTs in a single institution, 188 (74%) were performed with LMA and the remainder with ETT. They reported a significant reduction in early complications (bleeding <24 hours, pneumothorax, accidental extubation and cuff rupture) in the LMA group (2.12 vs 9.09%, P=0.022). It is difficult to see how the use of the LMA could impact upon the risk of bleeding, but even with this removed from the statistical analysis the reduction in complications remains significant (0.53 vs 6.06%, P=0.017) 12 . There were no late complications in either group. Subjectively, endoscopic visualisation of the trachea was better in the LMA group. However this was not a randomised study, the anaesthetists involved were free to choose which airway device was used and the overall complication rate was low.
The first randomised trial comparing the LMA and ETT for percutaneous dilatational tracheostomy was reported by Ambesh et al 15 who assigned 60 patients to either ETT or LMA (size 3 for females and size 4 for males). PDT was performed by Ciaglia's method and patients were excluded from the study if they had an unstable cervical spine, gross thyroid swelling, prothrombin time >20 seconds or positive end-expiratory pressure greater than 5 cmH 2 O. Complications were significantly higher in the LMA group (33.2 vs 16.6%, P <0.05). This included five patients in the LMA group in whom satisfactory ventilation was not possible and required reintubation prior to commencing PDT. The authors' conclusion is highly critical of the use of LMA for PDT and in particular, the high number of patients in whom satisfactory ventilation could not be achieved (16.7%). Other authors have, however, questioned the appropriateness of the sizing of the LMAs used in this study 16 .
A similar study by Dosemeci and colleagues 17 (LMA n=28, ETT n=30) using bronchoscopic guidance and the Griggs Forceps method found a lower incidence of complications in the LMA group (7.7 vs 26.7%, P=0.09). However, in two patients insertion of the LMA was impossible and these were excluded from the study and subsequent statistical analysis. If an intention-to-treat analysis is performed to include failed insertion as a complication (as per Ambesh et al), the reduction in complications is less (14.3 vs 26.7%, P=0.25) 12 . The authors demonstrated a significant decrease in both procedure time (4.5±0.8 vs 5.9±1.4 minutes, P=0.001) and rise in P a CO 2 during PDT (4.5±2.4 vs 6.8±3.9 mmHg, P=0.01), though the latter did not significantly reduce the number of patients with post-procedure hypercarbia (defined as P a CO 2 >40 mmHg) (38.5 vs 56.7%, P=0.28).
Di Pietro et al 16 studied 60 patients randomised to either LMA or ETT. The inclusion criteria allowed for positive end-expiratory pressure of up to 12 cmH 2 O. In the ETT group, the existing tube was replaced (8.5 mm internal diameter for females and 9.0 mm internal diameter for males) prior to PDT. In the LMA group a size 4 was used for females and a size 5 for males. All PDTs were performed using the Blue Rhino single dilator method under bronchoscopic guidance. There was one patient in the LMA group who was impossible to ventilate and one inadvertent extubation in the ETT group, both of whom were re-intubated. There were no other documented complications. Potential advantages in the LMA group were a statistically significant reduction in P a CO 2 immediately after placement of the tracheostomy (40.2 vs 44.2 mmHg, P <0.0001) and median duration of PDT (8.45 vs 9.80 minutes, P=0.002), but no outcome data was presented to allow interpretation of the clinical significance of these findings.
A further randomised controlled trial presented as an abstract 18 studied 73 patients (LMA n=31, ETT n=42) and found no significant difference in complications between the two groups (25.8 vs 26.2%, P=0.971), though the complications experienced were not reported.
Lindstedt published two papers examining the effect of the LMA on visualisation of intratracheal structures and ventilation. The first 19 was an observational study of the intubating LMA in 86 patients. Good or very good ventilation was reported in 80% of patients. Good or very good visualisation of the trachea was observed in 90% of patients before, and in 85% during, PDT. Only four patients (5%) were impossible to ventilate with the intubating LMA.
The second paper 20 sought to confirm the apparent superiority of the LMA in a controlled trial. The authors randomised 66 patients to undergo bronchoscopic-guided PDT via LMA or ETT and used a standardised rating scale to grade ease of use, visualisation of tracheal structures and quality of ventilation (1=best, 4=impossible). The study design required that if any step of the procedure was impossible with the randomised airway it was changed to the alternative route and all subsequent steps were rated 4. The baseline demographics of the two groups were comparable, though 46 patients (73%) were classified as "neurosurgery". The time to complete PDT was similar in both groups. There was a statistically significant improvement in visualisation of intratracheal structures in the LMA group, with only one patient not rated 'good' or 'very good' compared with 11 in the ETT group. The authors attribute this advantage to the ability to position the tip of the bronchoscope at the level of the vocal cords, allowing for identification of the thyroid cartilage and hence "more reliable and easy definition of the cricoid and tracheal rings". It should be noted that this study was based predominantly on subjective assessments and no blinding was employed, so the risk of bias is high.
The difficulties reported by several authors with achieving satisfactory ventilation via an LMA following prolonged intubation were investigated by Carron et al 21 . Two groups of 30 consecutive patients were studied, the first having been intubated for less than four days (short-term intubation group) and the second for longer than 12 days (long-term intubation group). Patients were excluded if they had airway or oesophageal pathology or previous surgery, had abnormal coagulation, were requiring FiO 2 >0.70 or positive end-expiratory pressure >10 cmH 2 O or had a previous difficult intubation. Following replacement of the ETT with a LMA the larynx was visualised endoscopically and the severity of mucosal lesions scored on a standardised rating scale. Peak airway pressures were recorded and the gas leakage fraction was calculated from the difference between inspiratory volumes and expiratory volumes, expressed as a fraction of inspiratory volume. All patients were adequately ventilated with the LMA, though three patients in each group required more than one attempt at insertion. There was a significant difference in the severity of laryngeal lesions between the two groups (P <0.05), with milder lesions in the short-term intubation group and more severe lesions in the long-term intubation group. This corresponded with an increased leakage fraction (18±3 vs 11±4%, P <0.01) and small increase in peak airway pressure (21.8±1.6 vs 19.5±2.3 cmH 2 O, P <0.05) in the long-term intubation group.
CRITICAL APPRAISAL
It is argued that the ETT represents the only true secure airway during PDT and exchange for an LMA exposes critically ill patients to unnecessary risk 22 . However, withdrawal of the ETT to the proximal position required for PDT, coupled with deflation of the cuff, does not represent a secure airway as both accidental extubation and aspiration may occur 3 . Similarly there is risk of damage to the ETT or cuff during PDT 2 .
There is reasonable evidence to show improved endoscopic visualisation of the trachea with the LMA 20 . The role of bronchoscopy in PDT remains controversial 23, 24 , but its use may avoid some of the more serious early complications of this technique, including creation of a false passage, posterior tracheal puncture and perforation of the oesophagus. The use of a bronchoscope may adversely affect ventilation during PDT as a 5.5 mm bronchoscope will occupy 37% of the cross-sectional area of a 9 mm ETT and 62% of a 7 mm tube. The larger diameter of the LMA will reduce this effect and several studies have demonstrated this in clinical practice 16, 17, 20 . The better ventilation afforded by the LMA may find increasing favour in patients where it is prudent to avoid hypercarbia, though the quoted effect 16, 17 is sufficiently small to present significant difficulty in designing an adequately powered study to detect a clinical effect.
The effect of the LMA on complication rates remains unclear and the evidence is conflicting. Quoted complication rates for PDT with an ETT are in the region of 5 to 10% 25, 26 , but in the papers presented the complication rate in the ETT groups have been as high as 26 .7% 17 and in the LMA groups up to 33.2% 15 . Many factors may explain this, including small sample size and inconsistent criteria for defining early and late complications. Furthermore, techniques for PDT insertion have progressed from serial dilatation to blunt dissection and now a predominance of a single dilator technique 27 , each of which has a unique risk profile.
Early papers pointed to an association between length of intubation and difficult LMA ventilation, but this was not borne out in a controlled trial 21 . The ideal timing for PDT remains unclear, though the results of some small studies have linked early (<7 days) tracheostomy with improved outcomes 28 . Only one of the randomised controlled trials presented provides information on the timing of tracheostomy, so it is unclear whether the LMA would have particular benefit for tracheostomies at a certain stage.
Caution should be used when interpreting papers with a high proportion of neurosurgical patients 20 , in whom the incidence of primary lung pathology may be lower than a general intensive therapy unit population. This may bias evidence in favour of the LMA and make extrapolation of findings to the general intensive therapy unit population difficult.
In view of the evidence presented, we cannot currently recommend the routine use of the LMA during PDT due to persistent problems with ventilation and the ongoing uncertainty of the safety of the technique. It is possible that in experienced hands some of the technical advantages demonstrated may translate into improved patient outcomes, but no research to date has been designed to detect this.
